DARK LABS – CRACK PRIMAL EDITION 432 G Dark Labs

£53.00

DARK LABS CRACK PRIMAL EDITION is a DMHA-based thermogenic research compound containing 2-aminoisoheptane and synergistic stimulant compounds for advanced metabolic research. Lab-grade 432g formulation for in-vitro investigation only.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
DARK LABS – CRACK PRIMAL EDITION 432 G Dark Labs
DARK LABS – CRACK PRIMAL EDITION 432 G Dark Labs
£53.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Compound Profile: DARK LABS – CRACK PRIMAL EDITION 432 G Dark Labs

DARK LABS CRACK PRIMAL EDITION is a DMHA-based thermogenic research compound formulated for advanced metabolic investigation. This 432g research-grade preparation contains 2-aminoisoheptane (DMHA) as the primary compound, combined with synergistic stimulant alkaloids and nootropic agents designed for comprehensive in-vitro metabolic pathway studies. The formulation represents a sophisticated research tool for laboratories investigating thermogenic mechanisms, adrenergic receptor interactions, and energy expenditure pathways in cellular models. Researchers at Stroid UK Shop utilise this compound to examine the complex interplay between sympathomimetic agents and cellular energy metabolism.

Laboratory Applications

Research institutions examine CRACK PRIMAL EDITION for its multi-compound thermogenic matrix effects on cellular energy systems. The DMHA component serves as a potent norepinephrine reuptake inhibitor, allowing researchers to investigate sympathetic nervous system pathway modulation in controlled laboratory environments. Studies focus on the compound’s interaction with β-adrenergic receptors, thermogenesis induction pathways, and metabolic rate enhancement mechanisms. Laboratory protocols evaluate the synergistic effects of combined stimulant compounds on lipolytic enzyme activation and cellular ATP production. Research teams investigating thermogenic compounds analyse this formulation alongside other metabolic modulators for comparative efficacy studies. Advanced research protocols examine the compound’s effects on mitochondrial function, examining similarities to research conducted with selective androgen receptor modulators and peptide compounds in metabolic research contexts.

Product Specifications

DARK LABS CRACK PRIMAL EDITION Research Specifications
Parameter Specification
Net Weight 432g
Primary Compound DMHA (2-Aminoisoheptane)
Form Powder preparation
Manufacturer Dark Labs
Storage Requirements Cool, dry conditions
Research Applications Thermogenic pathway studies
Compound Class Stimulant alkaloid complex

Research Compliance

DARK LABS CRACK PRIMAL EDITION is intended exclusively for qualified research applications in controlled laboratory environments. This product is not approved for human consumption and must be handled according to institutional safety protocols for research chemicals. Investigators must maintain proper documentation and adhere to applicable research guidelines when conducting studies with this material. This compound is sold strictly for in-vitro research purposes only.

Related